Hemostasis at Scale: How the UR8000 Automates the Bottleneck

UR8000 Coagulation Analyzer – High-Throughput Automated Hemostasis Testing System

The UR8000 is a fully automated hemostasis testing system built for high-volume clinical labs. Its core specification—900 tests per hour across 40 detection channels—places it squarely in the tier of instruments designed to handle the throughput of a regional hospital or diagnostic network.

What matters operationally is the integration. The system runs coagulation, immunoturbidimetric, and chromogenic assays on a single platform, eliminating the need for separate workstations for PT, APTT, FIB, or D-Dimer panels. For a lab manager, that means fewer instruments to maintain and calibrate—and a simpler path to standardization.

Automation runs deep. The UR8000 detects hemolysis, icterus, and lipemia automatically, flagging compromised samples before they consume reagent time. Closed-tube sampling and cap-piercing reduce biohazard exposure, while barcode tracking ensures chain-of-custody integrity. These are not luxuries; they are baseline requirements for labs seeking ISO 15189 accreditation.

Beneath the hardware lies a procurement reality. Instruments at this throughput level are typically paired with proprietary reagents and consumables, locking in long-term supply contracts. For hospital purchasing departments, the UR8000 represents a capital commitment that reshapes reagent budgets, training pipelines, and maintenance schedules for years.

China’s diagnostic equipment sector has advanced rapidly in this category. The UR8000 competes directly with legacy systems from Siemens and Stago, offering comparable throughput at a price point that changes the calculus for mid-tier hospitals upgrading from semi-automated workflows. It is part of a broader shift: domestic automation platforms are compressing the replacement cycle in China’s clinical lab infrastructure.

The real signal is not the hardware. It is that the bottleneck in hemostasis testing is no longer the instrument—it is the sample pipeline feeding it.

Why it matters:
For lab directors, the UR8000 compresses decision-to-result time in coagulation panels—critical in surgical and trauma settings. For procurement teams, it signals a viable domestic alternative in a segment long dominated by European and Japanese vendors.

View Product →